Skretting and eniferBio agreed to expand their cooperation with a new MoU on testing PEKILO® protein in Atlantic salmon and rainbow trout.
The partnership between eniferBio and Skretting has been strengthened by the signing of an agreement that defines the future steps for testing PEKILO® protein in Atlantic salmon and rainbow trout.
Skretting and eniferBio have signed a Memorandum of Understanding (MoU) on continued cooperation. The biotech start-up was the winner of the 2020 Nutreco Feed & Food Tech Challenge. This biannual competition acknowledges the best breakthrough innovations within livestock farming, aquaculture, and alternative food proteins. The first prize included a scientific validation trial.
The first performance tests on PEKILO® with Atlantic salmon were run in 2021 with promising results. In unison with the signing of the agreement, eniferBio has now provided a new batch of PEKILO® protein for the next phases of testing its performance as aqua feed with Atlantic salmon, and the first performance testing rounds with rainbow trout.
NEXT STEPS TOWARDS COMMERCIALISATION OF PEKILO® PROTEIN
“The MoU defines the next steps towards commercialisation of PEKILO® protein and implementation into Skretting feeds, in line with our sustainability ambitions of including 5–10% of novel ingredients into our formulations by 2025. There is a strong intention from both parties to reach large commercial volumes of this low carbon, high protein novel raw material; first in Europe and subsequently in other geographies,” says Mette Lütcherath, Category Manager Novel Ingredients at Nutreco.
“Skretting is a leading manufacturer and supplier of aquaculture feeds, so it is significant to get help from a major company like them in getting our innovation out there. We are thrilled that the first round of performance tests was a success, and we can continue the partnership,” adds Joosu Kuivanen, COO and Co-founder of eniferBio.
